Recent Quotes (30 days)

You have no recent quotes
chg | %

IntelGenx Technologies Corp.  

(Public, OTCMKTS:IGXT)   Watch this stock  
Find more results for OTC:IGXT
Dec 19 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range     -
52 week 0.33 - 1.18
Open     -
Vol / Avg. 0.00/250,160.00
Mkt cap 36.18M
P/E     -
Div/yield     -
EPS -0.04
Shares 63.47M
Beta 56.71
Inst. own     -

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -96.02% -172.89%
Operating margin -98.45% -172.89%
EBITD margin - -165.30%
Return on average assets -29.16% -31.59%
Return on average equity -33.29% -45.62%
Employees 12 -
CDP Score - -


6425 Abrams
+1-514-3317440 (Phone)

Website links


IntelGenx Technologies Corp. is a drug delivery company focusing on the development of orally administered drug delivery products based on its oral drug delivery technologies. The Company is a provider of product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets. Its product development are based upon three delivery platform technologies: VersaTab, a Multilayer Tablet technology; VersaFilm, an Oral Film technology, and AdVersa, a Mucoadhesive Tablet technology. Its Multilayer Tablet platform technology allows for the development of oral controlled-release products. The Oral Film technology allows for the instant delivery of pharmaceuticals to the oral cavity, while the Mucoadhesive Tablet allows for the controlled release of active substances to the oral mucosa. The Multilayer Tablet platform technology represents a new generation of controlled release layered tablets designed to modulate the release of active compounds.

Officers and directors

Paul Anthony Simmons Chief Financial Officer
Age: 51
Ingrid Zerbe Director - Finance and Administration, Corporate Secretary
Age: 58
Horst G. Zerbe Ph.D. Chairman of the Board, President, Chief Executive Officer
Age: 67
J. Bernard Boudreau QC Independent Director
Age: 68
John Marinucci CPA Independent Director
Age: 55
Bernd J. Melchers Independent Director
Age: 61
Ian Troup Independent Director
Age: 70